NCT04079101View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

December 27, 2019

Study Completion Date

December 27, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

BIIB104

Administered as specified in the treatment arm.

DRUG

Placebo

Administered as specified in the treatment arm.

Trial Locations (1)

90806

Research Site, Long Beach

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY